ADCK2 and melanoma: Analyzing expression data from two datasets from the cBioPortal database (https://www.cbioportal.org/ accessed on 12 October 2021) revealed that a lower ADCK2 expression in melanomas correlates with a worse patient prognosis while a higher expression positively affects the survival (Figure 1B).